|
Volumn 60, Issue SUPPL. 150, 2006, Pages 14-16
|
Implication of clinical studies for the Asian population: Focus on Chinese/Asian population
|
Author keywords
Asians; Blood pressure control; Chinese population; Clinical studies; Hypertensive therapy; Systolic hypertension
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CALCIUM ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FELODIPINE;
HYDROCHLOROTHIAZIDE;
INDAPAMIDE;
NICARDIPINE;
NIFEDIPINE;
NITRENDIPINE;
PERINDOPRIL;
PLACEBO;
TRICHLORMETHIAZIDE;
VALSARTAN;
ARTICLE;
ASIAN;
BLOOD PRESSURE REGULATION;
CAUSE OF DEATH;
CHINA;
CHINESE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESPONSE;
HUMAN;
HYPERTENSION;
LOW DRUG DOSE;
MORTALITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
UNSPECIFIED SIDE EFFECT;
|
EID: 33748943664
PISSN: 13685031
EISSN: 17421241
Source Type: Journal
DOI: 10.1111/j.1742-1241.2006.01118.x Document Type: Article |
Times cited : (1)
|
References (7)
|